People · Operator
Named in public records as an officer, director or promoter · active 2011–2023 · Manufacturing, Pharmaceuticals, Other
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Fasthouse, Inc. | — | Manufacturing | Seed | $1.5M | $18.4M | 2019 |
| Chrysalis Biotherapeutics, Inc. | — | Pharmaceuticals | Pre-Seed | $515K | $3.3M | 2023 |
| Rated P Ltd Liability Co | — | Other | Pre-Seed | $271K | $6.3M | 2011 |
Timothy Schmidt at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Timothy Schmidt on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Jeffery Sheldon | 1 | 3 |
| Darrell Carney | 1 | 1 |
| James Ryaby | 1 | 1 |
| Marie Robb | 1 | 1 |
| Jason Fontes | 1 | 1 |
| Daniel Worrell | 1 | 1 |
| Kenneth Alexander | 1 | 1 |
| Amber Alexander | 1 | 1 |
| Lauri Sower | 1 | 1 |
| Byron Besse, Jr. | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.